Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
- Status
- RECRUITING
- Phase
- N/A
Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE2
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
- Status
- RECRUITING
- Phase
- PHASE2
Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof Mutation
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types
- Status
- TERMINATED
- Phase
- PHASE1
A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CIML NK Cell in Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1